MedPath
HSA Approval

RAFUSTER SOFT CAPSULES 0.5 MG

SIN15882P

RAFUSTER SOFT CAPSULES 0.5 MG

RAFUSTER SOFT CAPSULES 0.5 MG

January 31, 2020

TRIKIN MARKETING PRIVATE LIMITED

CHEMKRAFT PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTRIKIN MARKETING PRIVATE LIMITED
Licence HolderCHEMKRAFT PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, LIQUID FILLED

ORAL

Medical Information

G04CB02

dutasteride

Manufacturer Information

CHEMKRAFT PTE. LTD.

GAP SA

Active Ingredients

Dutasteride

0.5 mg

Dutasteride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RAFUSTER SOFT CAPSULES 0.5 MG - HSA Approval | MedPath